Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product

Bone Marrow Transplant. 2016 Dec;51(12):1631-1632. doi: 10.1038/bmt.2016.236. Epub 2016 Sep 26.

Authors

L Bai^{1

2}, L Peters^{1

2}, W Xia^{1

2}, G Best², K Wong¹, C Ward¹, M Greenwood¹

Affiliations

¹ Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
² Cellular Therapeutic Laboratory, Department of Haematology, Northern Blood Research Centre, Kolling Research Institute, Sydney, NSW, Australia.

PMID: 27668761
DOI: 10.1038/bmt.2016.236

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Apoptosis
Cell Survival
Cryopreservation / methods*
DNA Damage
Hematopoietic Stem Cells / cytology*
Hodgkin Disease / blood
Hodgkin Disease / therapy
Humans
Linear Models
Lymphoma, Non-Hodgkin / blood
Lymphoma, Non-Hodgkin / therapy
Membrane Potentials
Multiple Myeloma / blood
Multiple Myeloma / therapy
Oxygen / chemistry
Phenotype
Pilot Projects
Reactive Oxygen Species / metabolism
Signal Transduction
Stem Cells / cytology*

Substances

Reactive Oxygen Species
Oxygen